Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 28Prostatic Neoplasms 14Neoplasm Metastasis 12Osteoporosis 8Multiple Myeloma 8Pain 7Lung Neoplasms 4Fractures, Bone 4Carcinoma, Non-Small-Cell Lung 4Neoplasms, Plasma Cell 3Humoral Hypercalcemia Of Malignancy 3Bone Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Paraproteinemias 1Osteosarcoma 1Neoplastic Processes 1Lymphoma, Non-Hodgkin 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Diseases 1Giant Cell Tumor of Bone 1Disease Progression 1

Interventions

Lenalidomide 3capivasertib 2Bortezomib 2tivozanib 1Zoledronic Acid 1Vitamin D 1Temozolomide 1Radiotherapy 1Nivolumab 1Gemcitabine 1Fulvestrant 1Etoposide 1Dexamethasone 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1Calcium 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Disease Progression × Zoledronic Acid × Clear all
NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡